CY1107742T1 - Εισπνεομενα φαρμακευτικα προϊοντα που περιεχουν ενα νεο αντιχολινεργικο σε συνδυασμο με κορτικοστεροειδη και βητα-μιμητικα - Google Patents

Εισπνεομενα φαρμακευτικα προϊοντα που περιεχουν ενα νεο αντιχολινεργικο σε συνδυασμο με κορτικοστεροειδη και βητα-μιμητικα

Info

Publication number
CY1107742T1
CY1107742T1 CY20071101217T CY071101217T CY1107742T1 CY 1107742 T1 CY1107742 T1 CY 1107742T1 CY 20071101217 T CY20071101217 T CY 20071101217T CY 071101217 T CY071101217 T CY 071101217T CY 1107742 T1 CY1107742 T1 CY 1107742T1
Authority
CY
Cyprus
Prior art keywords
beta
combination
corticosteroid
inhalated
anticolinergic
Prior art date
Application number
CY20071101217T
Other languages
English (en)
Inventor
Michel Pairet
Christopher John Montague Meade
Michael Paul Pieper
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of CY1107742T1 publication Critical patent/CY1107742T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Abstract

Η παρούσα εφεύρεση αφορά καινοτόμες φαρμακευτικές συνθέσεις με βάση ένα νέο αντιχολινεργικό, κορτικοστεροειδή και βήτα-μιμητικά, μέθοδο για την παραγωγή τους καθώς και τη χρήση τους στη θεραπεία παθήσεων των αναπνευστικών οδών.
CY20071101217T 2002-08-17 2007-09-19 Εισπνεομενα φαρμακευτικα προϊοντα που περιεχουν ενα νεο αντιχολινεργικο σε συνδυασμο με κορτικοστεροειδη και βητα-μιμητικα CY1107742T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10237739A DE10237739A1 (de) 2002-08-17 2002-08-17 Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
EP03793643A EP1530471B1 (de) 2002-08-17 2003-07-25 Inhalative arzneimittel enthaltend ein neues anticholinergikum in kombination mit corticosteroiden und betamimetika

Publications (1)

Publication Number Publication Date
CY1107742T1 true CY1107742T1 (el) 2013-04-18

Family

ID=30775387

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101217T CY1107742T1 (el) 2002-08-17 2007-09-19 Εισπνεομενα φαρμακευτικα προϊοντα που περιεχουν ενα νεο αντιχολινεργικο σε συνδυασμο με κορτικοστεροειδη και βητα-μιμητικα

Country Status (21)

Country Link
EP (2) EP1530471B1 (el)
JP (1) JP2006501253A (el)
KR (1) KR101083977B1 (el)
CN (1) CN1688308A (el)
AT (1) ATE366574T1 (el)
AU (1) AU2003255289B2 (el)
BR (1) BR0313526A (el)
CA (1) CA2495454C (el)
CO (1) CO5540380A2 (el)
CY (1) CY1107742T1 (el)
DE (2) DE10237739A1 (el)
DK (1) DK1530471T3 (el)
ES (1) ES2290549T3 (el)
IL (1) IL166891A (el)
MX (1) MXPA05001823A (el)
NZ (1) NZ538834A (el)
PL (1) PL212070B1 (el)
PT (1) PT1530471E (el)
RU (1) RU2332217C2 (el)
WO (1) WO2004022058A1 (el)
ZA (1) ZA200500019B (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1305329B2 (en) 2000-08-05 2015-03-18 Glaxo Group Limited 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
BR0209271A (pt) 2001-04-30 2004-06-15 Glaxo Group Ltd Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024453A1 (de) * 2004-05-14 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
US20060034776A1 (en) * 2004-08-10 2006-02-16 Boehringer Ingelheim International Gmbh Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics
DE102004056578A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid
DE102004056579A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
JP5259193B2 (ja) 2005-02-25 2013-08-07 チエシイ・ファルマセウテイシイ・エス・ペー・アー 加圧下にある用量計量型吸入器用の金属イオン封鎖剤を含む薬用エーロゾル配合物
EP2484382A1 (en) * 2005-03-30 2012-08-08 Schering Corporation Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form
JP2008538758A (ja) * 2005-04-23 2008-11-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬に加えてベータ受容体刺激薬及びステロイドを含有する吸入用の医薬組成物
JP5270343B2 (ja) 2005-08-15 2013-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベータミメティックスの製造方法
WO2009052624A1 (en) * 2007-10-25 2009-04-30 Merck Frosst Canada Ltd. Combination therapy
US9463161B2 (en) 2009-05-29 2016-10-11 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
RU2479304C1 (ru) * 2012-05-29 2013-04-20 Шолекс Девелопмент Гмбх, Стабильный раствор фенотерола гидробромида
RU2504382C1 (ru) * 2012-06-13 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
DK2934544T3 (en) 2012-12-21 2019-03-04 Boehringer Ingelheim Vetmedica Gmbh PHARMACEUTICAL FORMULA INCLUDING CICLESONID
CA2888428C (en) 2012-12-21 2021-07-13 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
ES2759247T3 (es) 2014-06-18 2020-05-08 Boehringer Ingelheim Vetmedica Gmbh Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003935D0 (en) * 2000-02-08 2000-04-12 King S College London Formulation for dry powder inhaler
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika

Also Published As

Publication number Publication date
RU2005107475A (ru) 2006-04-10
JP2006501253A (ja) 2006-01-12
CO5540380A2 (es) 2005-07-29
DE50307659D1 (de) 2007-08-23
EP1530471B1 (de) 2007-07-11
PT1530471E (pt) 2007-07-26
AU2003255289B2 (en) 2009-08-20
MXPA05001823A (es) 2005-04-19
BR0313526A (pt) 2005-06-28
EP1785136A2 (de) 2007-05-16
ZA200500019B (en) 2006-07-26
RU2332217C2 (ru) 2008-08-27
KR101083977B1 (ko) 2011-11-22
EP1530471A1 (de) 2005-05-18
DE10237739A1 (de) 2004-02-26
ATE366574T1 (de) 2007-08-15
NZ538834A (en) 2007-10-26
DK1530471T3 (da) 2007-10-22
ES2290549T3 (es) 2008-02-16
WO2004022058A1 (de) 2004-03-18
KR20050051644A (ko) 2005-06-01
CN1688308A (zh) 2005-10-26
IL166891A (en) 2010-04-15
EP1785136A3 (de) 2009-04-22
AU2003255289A1 (en) 2004-03-29
PL212070B1 (pl) 2012-08-31
CA2495454A1 (en) 2004-03-18
CA2495454C (en) 2011-09-06
PL375233A1 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
CY1107742T1 (el) Εισπνεομενα φαρμακευτικα προϊοντα που περιεχουν ενα νεο αντιχολινεργικο σε συνδυασμο με κορτικοστεροειδη και βητα-μιμητικα
ECSP055600A (es) Formulación aerosol para inhalación, que contiene un agente anticolinérgico
Danahy et al. Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate.
AR035589A1 (es) Esteres de acido difenilmetilcarboxilico con efecto anticolinergico, un procedimiento para su preparacion, el uso de los mismos para la preparacion de un medicamento y los preparados farmaceuticos que los contienen
Rischitelli et al. Safety and efficacy of controlled‐release oxycodone: a systematic literature review
RU2001125899A (ru) Фенильные и пиридинильные производные
BR0312507A (pt) Composições de medicamentos à base de novos anticolinérgicos e inibidores de egfr-cinase
RS50776B (sr) Medikamenti koji sadrže steroide i novi lek antiholinesteraze
RU2008108302A (ru) Применение солей тиотропия для лечения тяжелых форм персистирующей астмы
JP2010521997A (ja) 爪甲真菌症の自己治療を促進するための方法およびシステム
AU2003222290A1 (en) Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
CA2258965A1 (en) Useful formulations of acid addition salt drugs
PT1526848E (pt) Antagonistas dos receptores de opióides em sistemas transdérmicos contendo buprenorfina
DE50305263D1 (de) Difurylglykolsäuretropenolester als anticholinergika
AR039634A1 (es) Medicamento que contiene betamimeticos y un anticolinergico
TH65935A (th) ยาซึ่งประกอบรวมด้วยสเตอรอยด์ และแอนตีโคลิเนอร์จิคตัวใหม่
Baker et al. Normal pharmacokinetics of doxapramin in a patient with renal failure and hypothyroidism.
Mourouzis et al. Mepivacaine Alters Vascular Responsiveness to Vasoconstrictors in Aortic Rings from Normal and Aortic‐Banded Rats
TH85132A (th) พอลิมอร์ฟชนิดใหม่ของ n-เมธิล-n-(3-(3-[2-ไธอีนิลคาร์บอนิล]-ไพราซอล-[1,5-(อัลฟา)]-ไพริมิดีน-7-อิล)ฟีนิล)อะซิตามีด และสารผสมและวิธีที่เกี่ยวข้องกับสารดังกล่าว
JPS59168115U (ja) 測量用の測距ロ−プ巻取機
IT8420860A1 (it) Nuovi derivati bis-propanolamminici dotati di attività selettiva nei confronti dei diversi recettori beta-adrenergici, loro sali di addizione acida farmaceuticamente accettabili, metodi per prepararli e composizioni farmaceutiche che li contengono
TH31043A (th) สารอนุพันธ์ของเฟนิลเอทานอลอะมิโนเตตระลินคาร์บอกซาไมด์